目次

Executive Summary
Market overview

Market Landscape
Market ecosystem
Value chain analysis

Market Sizing
Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Type
Market segments
Comparison by Type
Allergic conjunctivitis - Market size and forecast 2020-2025
Bacterial conjunctivitis - Market size and forecast 2020-2025
Viral conjunctivitis - Market size and forecast 2020-2025
Market opportunity by Type

Customer landscape
Customer landscape

Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity By Geographical Landscape
Market drivers
Market challenges
Market trends

Vendor Landscape
Vendor landscape
Landscape disruption
Overview

Vendor Analysis
Vendors covered
Market positioning of vendors
AbbVie Inc.
Akorn Inc.
Bausch Health Companies Inc.
Merck and Co. Inc.
NovaBay Pharmaceuticals Inc.
Novartis AG
Pfizer Inc.
Santen Pharmaceutical Co. Ltd.
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.

Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2020 - 2025 ($ million)
13: Global market: Year-over-year growth 2020 - 2025 (%)
14: Five forces analysis 2020 & 2025
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2020
21: Type - Market share 2020-2025 (%)
22: Comparison by Type
23: Allergic conjunctivitis - Market size and forecast 2020-2025 ($ million)
24: Allergic conjunctivitis - Year-over-year growth 2020-2025 (%)
25: Bacterial conjunctivitis - Market size and forecast 2020-2025 ($ million)
26: Bacterial conjunctivitis - Year-over-year growth 2020-2025 (%)
27: Viral conjunctivitis - Market size and forecast 2020-2025 ($ million)
28: Viral conjunctivitis - Year-over-year growth 2020-2025 (%)
29: Market opportunity by Type
30: Customer landscape
31: Market share By Geographical Landscape 2020-2025 (%)
32: Geographic comparison
33: North America - Market size and forecast 2020-2025 ($ million)
34: North America - Year-over-year growth 2020-2025 (%)
35: Europe - Market size and forecast 2020-2025 ($ million)
36: Europe - Year-over-year growth 2020-2025 (%)
37: Asia - Market size and forecast 2020-2025 ($ million)
38: Asia - Year-over-year growth 2020-2025 (%)
39: ROW - Market size and forecast 2020-2025 ($ million)
40: ROW - Year-over-year growth 2020-2025 (%)
41: Key leading countries
42: Market opportunity By Geographical Landscape ($ million)
43: Impact of drivers and challenges
44: Vendor landscape
45: Landscape disruption
46: Industry risks
47: Vendors covered
48: Market positioning of vendors
49: AbbVie Inc. - Overview
50: AbbVie Inc. - Product and service
51: AbbVie Inc. - Key offerings
52: AbbVie Inc. - Key customers
53: AbbVie Inc. - Segment focus
54: Akorn Inc. - Overview
55: Akorn Inc. - Product and service
56: Akorn Inc. - Key offerings
57: Akorn Inc. - Key customers
58: Akorn Inc. - Segment focus
59: Bausch Health Companies Inc. - Overview
60: Bausch Health Companies Inc. - Business segments
61: Bausch Health Companies Inc. - Key offerings
62: Bausch Health Companies Inc. - Key customers
63: Bausch Health Companies Inc. - Segment focus
64: Merck and Co. Inc. - Overview
65: Merck and Co. Inc. - Business segments
66: Merck and Co. Inc. - Key offerings
67: Merck and Co. Inc. - Key customers
68: Merck and Co. Inc. - Segment focus
69: NovaBay Pharmaceuticals Inc.- Overview
70: NovaBay Pharmaceuticals Inc.- Product and service
71: NovaBay Pharmaceuticals Inc.- Key offerings
72: NovaBay Pharmaceuticals Inc.- Key customers
73: NovaBay Pharmaceuticals Inc.- Segment focus
74: Novartis AG - Overview
75: Novartis AG - Business segments
76: Novartis AG - Key offerings
77: Novartis AG - Key customers
78: Novartis AG - Segment focus
79: Pfizer Inc. - Overview
80: Pfizer Inc. - Business segments
81: Pfizer Inc. - Key offerings
82: Pfizer Inc. - Key customers
83: Pfizer Inc. - Segment focus
84: Santen Pharmaceutical Co. Ltd. - Overview
85: Santen Pharmaceutical Co. Ltd. - Business segments
86: Santen Pharmaceutical Co. Ltd. - Key offerings
87: Santen Pharmaceutical Co. Ltd. - Key customers
88: Santen Pharmaceutical Co. Ltd. - Segment focus
89: Sun Pharmaceutical Industries Ltd. - Overview
90: Sun Pharmaceutical Industries Ltd. - Business segments
91: Sun Pharmaceutical Industries Ltd. - Key offerings
92: Sun Pharmaceutical Industries Ltd. - Key customers
93: Sun Pharmaceutical Industries Ltd. - Segment focus
94: Teva Pharmaceutical Industries Ltd. - Overview
95: Teva Pharmaceutical Industries Ltd. - Business segments
96: Teva Pharmaceutical Industries Ltd. - Key offerings
97: Teva Pharmaceutical Industries Ltd. - Key customers
98: Teva Pharmaceutical Industries Ltd. - Segment focus
99: Currency conversion rates for US$
100: Research Methodology
101: Validation techniques employed for market sizing
102: Information sources
103: List of abbreviations